-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The UK government has announced that it will provide genomics expertise to the international community to help identify new variants of COVID-19.
countries that do not have the resources to identify the new strain of SARS-CoV-2 that causes COVID-19 will receive professional support from the UK.
new evaluation platform is currently led by Public Health England (PHE) and works with the NHS and the World Health Organization.
, the new platform will be led by the National Institutes of Health Protection (NIHP), the Department of Health and Social Care (DHSC) said in a statement.
Minister of Health and Social Care (DHSC), Matt Hancock, said: "The new coronavirus is still mutating, and our new mutation assessment platform will help us better understand the virus and how it is transmitted, and enhance global understanding of the coronavirus."
DHSC said the UK had taken on more than half of all SARS-CoV-2 genome sequences submitted to the global database.
previously, researchers at University College London looked at 46,723 Covid-19 cases from 99 countries to assess how mutations occurred and whether they changed their ability to spread, and scientists found 12,706 mutations in the SARS-CoV-2 virus that causes Covid-19.
